Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines

Ikuo Saito, Hiroshi Kawabe, Minako Tsujioka, Hiroshi Hirose, Hirotaka Shibata

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Hypertension, a major risk factor for cerebrovascular disease and heart disease, often requires drug therapy. The First Japanese Society of Hypertension Guidelines for the Management of Hypertension were published in June 2000. In the present work, we surveyed 447 doctors who attended continuing medical education meetings between March and July 2001 to elucidate national antihypertensive treatment patterns. A minimum level of 150/95 mmHg was selected by 60% and 140/90 mmHg by 19% of respondents as thresholds for initiating drug treatment, while 130/85 mmHg was selected by 26% of respondents as the goal blood pressure in middle-aged uncomplicated male patients. Sixty-nine percent of respondents selected a calcium antagonist as their previous drug of the first choice and 22% selected an ACE inhibitor. For their future first choice, 55% would prescribe an angiotensin II receptor antagonist (AIIA); 19% an ACE inhibitor; and 16% a calcium antagonist. Seventy-two percent selected a calcium antagonist + an ACE inhibitor and 17% selected a calcium antagonist + AIIA as their previous first-choice drug combinations. For their future drug combinations, 56% would select an AIIA + a calcium antagonist and 25% a calcium antagonist + an ACE inhibitor. Four weeks or less was selected by 69% of respondents as the period intended to reach the goal blood pressure. Eight weeks or more was selected by 28%. Overall, our data suggest that doctors in Japan are still cautious and conservative in controlling blood pressure levels but want rapid achievement of the goal blood pressure. Their first choice drug is shifting from calcium antagonists to AIIAs. These findings indicate the need for continued effort to evaluate the diversity of clinical practice and assess the appropriateness of continuing medical education.

Original languageEnglish
Pages (from-to)175-178
Number of pages4
JournalHypertension Research
Volume25
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Publications
Japan
Guidelines
Hypertension
Calcium
Angiotensin-Converting Enzyme Inhibitors
Angiotensin Receptor Antagonists
Blood Pressure
Continuing Medical Education
Drug Combinations
Pharmaceutical Preparations
Cerebrovascular Disorders
Antihypertensive Agents
Heart Diseases
Drug Therapy
Surveys and Questionnaires
Therapeutics

Keywords

  • Antihypertensive therapy
  • Blood pressure control
  • Drug combination
  • Survey

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. / Saito, Ikuo; Kawabe, Hiroshi; Tsujioka, Minako; Hirose, Hiroshi; Shibata, Hirotaka.

In: Hypertension Research, Vol. 25, No. 2, 2002, p. 175-178.

Research output: Contribution to journalArticle

Saito, Ikuo ; Kawabe, Hiroshi ; Tsujioka, Minako ; Hirose, Hiroshi ; Shibata, Hirotaka. / Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. In: Hypertension Research. 2002 ; Vol. 25, No. 2. pp. 175-178.
@article{bf1f56daa0dd4263b46951a6fc7597fb,
title = "Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines",
abstract = "Hypertension, a major risk factor for cerebrovascular disease and heart disease, often requires drug therapy. The First Japanese Society of Hypertension Guidelines for the Management of Hypertension were published in June 2000. In the present work, we surveyed 447 doctors who attended continuing medical education meetings between March and July 2001 to elucidate national antihypertensive treatment patterns. A minimum level of 150/95 mmHg was selected by 60{\%} and 140/90 mmHg by 19{\%} of respondents as thresholds for initiating drug treatment, while 130/85 mmHg was selected by 26{\%} of respondents as the goal blood pressure in middle-aged uncomplicated male patients. Sixty-nine percent of respondents selected a calcium antagonist as their previous drug of the first choice and 22{\%} selected an ACE inhibitor. For their future first choice, 55{\%} would prescribe an angiotensin II receptor antagonist (AIIA); 19{\%} an ACE inhibitor; and 16{\%} a calcium antagonist. Seventy-two percent selected a calcium antagonist + an ACE inhibitor and 17{\%} selected a calcium antagonist + AIIA as their previous first-choice drug combinations. For their future drug combinations, 56{\%} would select an AIIA + a calcium antagonist and 25{\%} a calcium antagonist + an ACE inhibitor. Four weeks or less was selected by 69{\%} of respondents as the period intended to reach the goal blood pressure. Eight weeks or more was selected by 28{\%}. Overall, our data suggest that doctors in Japan are still cautious and conservative in controlling blood pressure levels but want rapid achievement of the goal blood pressure. Their first choice drug is shifting from calcium antagonists to AIIAs. These findings indicate the need for continued effort to evaluate the diversity of clinical practice and assess the appropriateness of continuing medical education.",
keywords = "Antihypertensive therapy, Blood pressure control, Drug combination, Survey",
author = "Ikuo Saito and Hiroshi Kawabe and Minako Tsujioka and Hiroshi Hirose and Hirotaka Shibata",
year = "2002",
doi = "10.1291/hypres.25.175",
language = "English",
volume = "25",
pages = "175--178",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines

AU - Saito, Ikuo

AU - Kawabe, Hiroshi

AU - Tsujioka, Minako

AU - Hirose, Hiroshi

AU - Shibata, Hirotaka

PY - 2002

Y1 - 2002

N2 - Hypertension, a major risk factor for cerebrovascular disease and heart disease, often requires drug therapy. The First Japanese Society of Hypertension Guidelines for the Management of Hypertension were published in June 2000. In the present work, we surveyed 447 doctors who attended continuing medical education meetings between March and July 2001 to elucidate national antihypertensive treatment patterns. A minimum level of 150/95 mmHg was selected by 60% and 140/90 mmHg by 19% of respondents as thresholds for initiating drug treatment, while 130/85 mmHg was selected by 26% of respondents as the goal blood pressure in middle-aged uncomplicated male patients. Sixty-nine percent of respondents selected a calcium antagonist as their previous drug of the first choice and 22% selected an ACE inhibitor. For their future first choice, 55% would prescribe an angiotensin II receptor antagonist (AIIA); 19% an ACE inhibitor; and 16% a calcium antagonist. Seventy-two percent selected a calcium antagonist + an ACE inhibitor and 17% selected a calcium antagonist + AIIA as their previous first-choice drug combinations. For their future drug combinations, 56% would select an AIIA + a calcium antagonist and 25% a calcium antagonist + an ACE inhibitor. Four weeks or less was selected by 69% of respondents as the period intended to reach the goal blood pressure. Eight weeks or more was selected by 28%. Overall, our data suggest that doctors in Japan are still cautious and conservative in controlling blood pressure levels but want rapid achievement of the goal blood pressure. Their first choice drug is shifting from calcium antagonists to AIIAs. These findings indicate the need for continued effort to evaluate the diversity of clinical practice and assess the appropriateness of continuing medical education.

AB - Hypertension, a major risk factor for cerebrovascular disease and heart disease, often requires drug therapy. The First Japanese Society of Hypertension Guidelines for the Management of Hypertension were published in June 2000. In the present work, we surveyed 447 doctors who attended continuing medical education meetings between March and July 2001 to elucidate national antihypertensive treatment patterns. A minimum level of 150/95 mmHg was selected by 60% and 140/90 mmHg by 19% of respondents as thresholds for initiating drug treatment, while 130/85 mmHg was selected by 26% of respondents as the goal blood pressure in middle-aged uncomplicated male patients. Sixty-nine percent of respondents selected a calcium antagonist as their previous drug of the first choice and 22% selected an ACE inhibitor. For their future first choice, 55% would prescribe an angiotensin II receptor antagonist (AIIA); 19% an ACE inhibitor; and 16% a calcium antagonist. Seventy-two percent selected a calcium antagonist + an ACE inhibitor and 17% selected a calcium antagonist + AIIA as their previous first-choice drug combinations. For their future drug combinations, 56% would select an AIIA + a calcium antagonist and 25% a calcium antagonist + an ACE inhibitor. Four weeks or less was selected by 69% of respondents as the period intended to reach the goal blood pressure. Eight weeks or more was selected by 28%. Overall, our data suggest that doctors in Japan are still cautious and conservative in controlling blood pressure levels but want rapid achievement of the goal blood pressure. Their first choice drug is shifting from calcium antagonists to AIIAs. These findings indicate the need for continued effort to evaluate the diversity of clinical practice and assess the appropriateness of continuing medical education.

KW - Antihypertensive therapy

KW - Blood pressure control

KW - Drug combination

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=0036240054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036240054&partnerID=8YFLogxK

U2 - 10.1291/hypres.25.175

DO - 10.1291/hypres.25.175

M3 - Article

C2 - 12047031

AN - SCOPUS:0036240054

VL - 25

SP - 175

EP - 178

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 2

ER -